Nilgun Sayinalp Selected Research

CCG-141 protocol

12/2010

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nilgun Sayinalp Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 12/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2015 - 04/2007
3	Leukemia 12/2013 - 03/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 04/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2015
2	Amyloidosis 01/2015 - 03/2008
1	Sudden Infant Death (SID) 10/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2023
1	Aplastic Anemia (Anemia, Hypoplastic) 04/2021
1	COVID-19 01/2021
1	Cardiotoxicity 01/2021
1	Fibrosis (Cirrhosis) 08/2015
1	Pure Red-Cell Aplasia 01/2015
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2015
1	Pneumonia (Pneumonitis) 01/2015
1	Typhoid Fever (Typhoid) 01/2015
1	Parvoviridae Infections (Parvovirus Infection) 01/2015
1	Fever of Unknown Origin 01/2015
1	Inflammation (Inflammations) 10/2014
1	Legg-Calve-Perthes Disease (Perthes Disease) 10/2014
1	Thrombosis (Thrombus) 10/2014
1	Diarrhea 12/2010
1	Body Weight (Weight, Body) 12/2010
1	Weight Loss (Weight Reduction) 12/2010
1	Acute Promyelocytic Leukemia 12/2010
1	Myeloid Sarcoma (Chloroma) 01/2010
1	Multiple Organ Failure (MODS) 04/2009
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2008
1	Hemorrhage 10/2008
1	Refractory Anemia 03/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2008
1	Blast Crisis (Blast Phase) 04/2007
1	Thrombocytopenia (Thrombopenia) 12/2003
1	Thrombocytosis (Thrombocythemia) 12/2003

Drug/Important Bio-Agent (IBA)

4	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2015
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 08/2015
2	nilotinib FDA Link 01/2021 - 08/2015
2	CopperIBA 01/2015 - 03/2008
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	E-SelectinIBA 10/2014
1	SelectinsIBA 10/2014
1	P-SelectinIBA 10/2014
1	ReninIBA 12/2013
1	Carcinoembryonic AntigenIBA 12/2010
1	Hemoglobins (Hemoglobin)IBA 12/2010
1	AnthracyclinesIBA 12/2010
1	HLA-DR Antigens (HLA-DR)IBA 04/2009
1	Adenosine Triphosphate (ATP)IBA 10/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2008
1	Erythropoietin FDA Link 03/2008
1	Stem Cell FactorIBA 12/2003

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2021 - 04/2007
4	Hematopoietic Stem Cell Transplantation 10/2023 - 12/2013
3	Therapeutics 01/2020 - 12/2010
1	CCG-141 protocol 12/2010